Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor — the expression of the early CD69plus, CD71plus and the late CD25plus, CD26plus, HLA/DRplus activation markers on T CD4plus and CD8plus lymphocytes in squamous cell laryngeal carcinoma. Part II